Understanding Female Hormones: When to Test, Common Abnormalities, Causes and Corrections
Female hormones regulate many aspects of health: periods, fertility, mood, energy, bone health and sexual function. Hormonal changes are normal across life — puberty, monthly cycles, pregnancy, perimenopause and menopause — but sometimes tests are needed to clarify what’s happening, guide treatment and prevent complications.
This blog explains when to check hormone levels (including to confirm menopause, evaluate PCOS or fertility, and investigate other endocrine conditions), common hormonal abnormalities, typical causes and corrective approaches, plus how oral contraceptives (OCPs) and hormone replacement therapy (HRT) interact with thyroid and testosterone, and how weight gain and alcohol affect female hormones.
Please note we use the term Oestradiol. Oestrogen is the overall name for the different oestradiol steroid sex hormone. There are three in total: Oestradiol 1, Oestradiol 2 and you guessed it Oestradiol 3!
Oestradiol 2 is the one women have in abundance during reproductive years, then it declines during menopause leaving Oestradiol 1 as the dominant hormone.
Which hormones are commonly measured and why
- Follicle-stimulating hormone (FSH) and luteinising hormone (LH): assess ovarian function and menopause stage.
- Estradiol (E2): main circulating oestrogen; useful for ovarian reserve and menopausal status.
- Anti-Müllerian hormone (AMH): marker of ovarian reserve (how many eggs remain), often used in fertility assessment.
- Progesterone: confirms ovulation when measured at the right time in cycle.
- Testosterone and free androgen index: measure androgen excess seen in PCOS and other conditions.
- Prolactin: high levels can cause absent/irregular periods and milk production.
- Thyroid-stimulating hormone (TSH) with free T4 (and sometimes free T3): thyroid dysfunction affects menstrual cycles, fertility and mood.
- Cortisol and ACTH: investigate adrenal causes of hormonal disturbance when clinically indicated.
- SHBG (sex hormone–binding globulin): changes affect free testosterone and estrogen availability.
- Fasting glucose/HbA1c and lipid profile: metabolic consequences of hormonal disorders (e.g. PCOS).
- Pelvic ultrasound: structural assessment (ovaries, endometrium) often complements blood tests.
When to check hormone levels
To confirm menopause (or perimenopause)
- What to assess: FSH, LH, estradiol. Clinical context is key: menopause is a clinical diagnosis after 12 months of amenorrhoea (no periods). Bloods can help when the picture is unclear (e.g. persistent irregular bleeding, women on HRT or contraceptives, or younger women where premature ovarian insufficiency is suspected).
- Timing: Any time if periods absent for months. Note that FSH fluctuates in perimenopause and may not be definitive; repeat testing or measuring symptoms and serum estradiol can help.
- Example: A 52-year-old woman with hot flushes and 9 months of irregular cycles may have variable FSH; if still having bleeding, we may use ultrasound and discuss management rather than rely solely on one blood test.
For suspected PCOS (polycystic ovary syndrome)
- What to assess: testosterone, SHBG, free androgen index, LH/FSH ratio (though not diagnostic by itself), prolactin, TSH, fasting glucose/HbA1c, lipid profile. Pelvic ultrasound may show polycystic-appearing ovaries.
- Timing: Bloods can be taken irrespective of cycle if irregular; if regular cycles, perform in early follicular phase (days 2–5) for some hormones.
- Example: A 28-year-old with irregular periods, acne and weight gain should have androgen levels, glucose and lipids checked to confirm PCOS and assess metabolic risk.
For fertility evaluation
- What to assess: AMH (ovarian reserve), FSH, LH, estradiol (often on day 2–4 of cycle), progesterone mid-luteal (to confirm ovulation), and thyroid and prolactin. Semen analysis for partner and pelvic imaging as needed.
- Timing: AMH can be measured any time; FSH and estradiol early in cycle; progesterone ~7 days before expected period.
- Example: A 35-year-old trying to conceive for 9 months will be offered AMH to understand ovarian reserve and baseline investigations to guide fertility planning.
For other endocrine concerns (thyroid, adrenal, pituitary)
- What to assess: TSH/free T4 for thyroid symptoms (fatigue, weight changes, menstrual irregularities); cortisol/ACTH for adrenal symptoms; prolactin for amenorrhoea or galactorrhoea; pituitary imaging if indicated.
- Timing: TSH testing is straightforward any time; special testing for cortisol may require timed collections or suppression/stimulation tests.
- Example: A 40-year-old with weight loss, palpitations and irregular periods should have thyroid tests promptly.

Common hormone abnormalities, causes and typical corrections
Menopause and perimenopause
- Problem: Ovarian function declines — irregular cycles, hot flushes, sleep disturbance, mood changes, vaginal dryness, bone density loss.
- Causes: Age-related ovarian follicle depletion; premature ovarian insufficiency if before age 40 (autoimmune, genetic, iatrogenic like chemotherapy/surgery).
- Correction/management: Lifestyle support, HRT for symptom management and bone protection when appropriate, non-hormonal options for some symptoms, bone density monitoring and treatment as needed. Individualised discussion of risks/benefits.
Polycystic ovary syndrome (PCOS)
- Problem: Few or no periods, hirsutism ( facial or body hair in male pattern), acne, subfertility, insulin resistance, increased cardiovascular risk.
- Causes: genetic predisposition, insulin resistance driving ovarian androgen production, lifestyle factors (weight gain).
- Correction/management: Weight loss and exercise improve cycles and fertility; combined OCPs regulate periods and reduce androgens; metformin may improve insulin resistance and menstrual regularity; anti-androgens, hair removal therapies, fertility treatments when trying to conceive; screen and manage metabolic risks such as BP, lipids, glucose, insulin test.
Hyperprolactinaemia ( high prolactin)
- Problem: NO periods, galactorrhoea, infertility, low thyroid as a result of the high prolactin.
- Causes: Prolactin-secreting pituitary adenoma (prolactinoma), medications (antipsychotics, some antidepressants), hypothyroidism.
- Correction/management: Treat underlying cause — dopamine agonists (e.g. cabergoline, sometitmes used to stotp lactation) for prolactinomas, change causative medication if possible, treat hypothyroidism.
Thyroid dysfunction
- Problem: Hypothyroidism can cause heavy or irregular periods, fertility problems, fatigue and weight gain; hyperthyroidism can cause light or absent periods, weight loss, palpitations.
- Causes: Autoimmune thyroiditis (Hashimoto’s) for hypothyroid; Graves’ disease for hyperthyroid; postpartum thyroiditis; iodine issues less common in our region.
- Correction/management: Levothyroxine for hypothyroidism; antithyroid drugs, radioactive iodine or surgery for hyperthyroidism as appropriate. Treating thyroid dysfunction often restores regular cycles and improves fertility.
Androgen excess other than PCOS (e.g. adrenal causes)
- Problem: Virilisation (deepening voice, clitoromegaly) or milder hirsutism, acne.
- Causes: Rare adrenal tumours or congenital adrenal hyperplasia (rare), medication effects or PCOS (most common).
- Correction/management: Investigate with adrenal imaging and hormonal tests; treat tumours surgically, use medical suppression therapies as appropriate.
Premature ovarian insufficiency (POI)
- Problem: Early menopause symptoms, infertility, bone loss, cardiovascular risk.
- Causes: Autoimmune, genetic (e.g. Turner mosaicism), iatrogenic (chemotherapy, oophorectomy).
- Correction/management: HRT until around average menopause age to protect bone and cardiovascular health, fertility options (egg donation, assisted reproduction) if desired, psychological support.
How oral contraceptives (OCPs) and HRT affect hormones — and implications for thyroid and testosterone
- OCPs (combined oestrogen-progestin pills):
- Suppress the normal ovulatory cycle and reduce endogenous FSH/LH, estradiol and progesterone fluctuations — therefore they prevent pregnancy and regulate bleeding.
- Increase SHBG (sex hormone–binding globulin), which reduces free testosterone levels; this often improves acne and hirsutism but can mask true baseline testosterone levels when testing for PCOS. For accurate baseline androgen testing, OCPs should ideally be stopped (with clinical guidance) for several weeks before testing.
- Oestrogen in OCPs increases liver-produced binding proteins and can raise total thyroid binding globulin, causing higher total thyroid hormone levels but not usually changing free thyroid hormones or TSH in euthyroid people. In thyroid disease, starting or stopping OCPs can alter levothyroxine dose requirements because of changes in thyroid hormone binding proteins.
- OCPs may modestly affect glucose and lipid metabolism.
- Progestin-only contraceptives:
- Less effect on SHBG and androgens; may not suppress ovulation consistently (except implants/IUDs) and may cause irregular bleeding.
- Hormone replacement therapy (HRT):
- Used to relieve menopausal symptoms; systemic oestrogen increases SHBG similarly to OCPs and can lower free testosterone.
- HRT may alter total thyroid hormone measures due to increased thyroid-binding globulin; thyroid hormone replacement doses may need adjustment when starting or stopping HRT.
- Choice of route matters: transdermal oestrogen has less impact on clotting factors and possibly different metabolic effects compared with oral oestrogen.
- Thyroid interactions summary:
- Oestrogens (in OCPs or HRT) increase thyroid-binding proteins so total T4/T3 rise but free hormone usually stable; however, people on levothyroxine may need dose changes when starting/stopping oestrogen-containing treatments. Always check TSH and symptoms.
- Testosterone interactions summary:
- OCPs and HRT (estradiol component) increase SHBG and reduce free testosterone, which can be beneficial if androgens are causing symptoms; but this suppresses the ability to measure true endogenous androgen production while on therapy.
Effects of weight gain and alcohol on female hormones
- Weight gain and adiposity:
- Fat tissue is hormonally active. Increased adiposity increases peripheral conversion of androgens to oestrogen (aromatase activity), which can lead to more estrogen exposure and menstrual irregularities. In PCOS, weight gain worsens insulin resistance, raising ovarian androgen production and worsening cycle irregularity and infertility.
- Excess weight increases risks of earlier menopause symptoms in some cases, worsens fertility outcomes, and raises the risk of metabolic syndrome, type 2 diabetes and cardiovascular disease.
- Correction: Weight loss (5–10% body weight) often improves menstrual regularity, ovulation and metabolic markers. Lifestyle changes (diet, physical activity), behavioural support and pharmacotherapy or bariatric surgery in selected cases are options.
- Alcohol:
- Regular heavy alcohol intake affects the endocrine system: it may increase oestrogen levels (by altering liver metabolism), impair ovulation and disrupt menstrual cycles, and worsen liver-related hormone metabolism.
- Alcohol can aggravate polycystic ovarian syndrome metabolic features and interfere with fertility treatments.
- Correction: Reducing alcohol intake often improves cycle regularity, fertility outcomes and overall health. Our clinic can offer brief interventions and referrals for support if needed.
Our approach in the clinic
- Individualised care: Hormone testing and interpretation depend on age, symptoms, medications (OCP/HRT), reproductive plans and comorbidities. We emphasise shared decision-making.
- Practical steps we typically follow:
- We take a focused history (symptoms, cycle pattern, contraception, medications, family history, weight changes, alcohol intake).
- Perform targeted physical exam (weight/BMI, blood pressure, signs of androgen excess, thyroid exam).
- Order appropriate baseline tests timed to the cycle where relevant (e.g. early follicular FSH/estradiol for fertility; AMH any time).
- Use pelvic ultrasound if indicated (PCOS features, abnormal bleeding).
- Manage initial issues in primary care (lifestyle, contraception choices, symptom control, vaginal swabs to rule out infection if periods are heavy ) and refer to endocrinology/gynaecology/fertility services for complex cases or where specialised treatments are needed.
When to refer
- Young women with suspected premature ovarian insufficiency (before age 40).
- Suspected pituitary or adrenal tumours, significant hyperprolactinaemia, virilisation, severe thyroid disease or uncontrolled metabolic complications of PCOS.
- Fertility assessment beyond initial investigations, or need for assisted reproductive technologies.
Key takeaways
- Hormone testing is useful when tailored to the clinical question: confirming menopause, diagnosing PCOS, evaluating fertility, or investigating other endocrine issues.
- Medications like OCPs and HRT change hormone test results (especially SHBG, free testosterone and total thyroid hormones), so testing and interpretation must account for current therapies.
- Weight gain and alcohol negatively impact hormone balance and fertility; lifestyle modification is a cornerstone of correction.
- Most hormone problems have effective management options — from lifestyle change through medical therapy to referral for specialist care — and your care plan should reflect your life goals (fertility desire, symptom control, long-term health).
If you’re worried about your hormones and have symptoms (irregular periods, trouble conceiving, hot flushes, excessive hair growth, sudden weight change, or fatigue), book an appointment with one of our female GP’s. We’ll take a full history, discuss whether hormone tests are appropriate, and plan individualised care with clear explanations of testing timing and possible treatments.
When to check FSH and estradiol/oestrogen to identify perimenopause, versus diagnosis of perimenopause from symptoms when age 40–45
Why test on day 1 (or days 1–3) of the cycle?
Physiology: In a normal cycle the pituitary releases FSH early in the follicular phase to recruit follicles and stimulate estradiol production. Measuring FSH and estradiol early (day 1–3 of bleeding) gives a standardised point to compare results between women and over time.
Practical reason: Early follicular FSH is less influenced by the later surge of LH/ovulation and therefore is the most reliable time to assess baseline ovarian follicular activity.
What the results mean (practical guidance)
Normal/young reproductive range: FSH is typically low–normal (varies by lab). Estradiol is within premenopausal range.
Perimenopause: FSH becomes variable and often intermittently elevated. A single elevated FSH on day 1–3 (for example, values above ~25–30 IU/L depending on lab reference) suggests reduced ovarian reserve/early ovarian failure activity, especially if estradiol is low. However, FSH fluctuates in perimenopause — one normal FSH does not exclude perimenopause.
Menopause: After 12 months of no periods/menstruation FSH is usually consistently high (often >30–40 IU/L) and estradiol low. A single high FSH in a woman with absent periods for many months supports menopause.
Limitations and practical points about hormone tests in perimenopause.
Variability: In perimenopause FSH can be high one cycle and normal the next. That’s why clinical context (age, symptoms, pattern of bleeding) is as important as one blood result.
Oestradiol adds useful information: A low estradiol with raised FSH supports declining ovarian function. A normal or high estradiol with high FSH is possible early in perimenopause (due to intermittent ovarian activity) and can complicate interpretation.
Age and symptoms matter: From around age 40–45, the development of persistent menstrual irregularity (cycles becoming shorter or longer, missed periods, heavier or lighter bleeding) plus typical symptoms (hot flushes, sleep disturbance) is commonly used to diagnose perimenopause clinically without needing blood tests.
When to repeat tests: If results and symptoms don’t match, repeat testing (another early-follicular sample) or use serial clinical review. If a woman is on combined OCPs or HRT these tests will be unreliable for assessing ovarian function unless stopped appropriately first.
Special situations: In younger women (under 40) with irregular periods or symptoms, raised FSH/E2 should prompt evaluation for premature ovarian insufficiency and usually urgent referral.
How we use this in clinic
– Age <40 with irregular bleeding or symptoms → measure FSH/estradiol and investigate causes (and refer if FSH persistently high).
– Age 40–45 with new persistent irregular cycles and typical perimenopausal symptoms → often diagnosed clinically; bloods may be helpful if the picture is unclear or contraception/HRT use complicates interpretation.
– Age >45 with irregular cycles → testing can support the diagnosis but is not always necessary; management focuses on symptoms, contraception needs and bone/cardio risk assessment.
As always this is not direct medical advice to you, please see one of our female doctors as sometimes irregular periods can be related to an underlying infection which has no other symptoms or it can be an over or under-active thyroid or stress or something affecting your prolactin level. So please come in and see us.
You can book online with either Dr Sarah O’Hagan or Dr Jen Mckew